Advances in spiral fMRI: A high-resolution study with single-shot acquisition.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 19 01 2020
revised: 23 10 2021
accepted: 15 11 2021
pubmed: 21 11 2021
medline: 22 2 2022
entrez: 20 11 2021
Statut: ppublish

Résumé

Spiral fMRI has been put forward as a viable alternative to rectilinear echo-planar imaging, in particular due to its enhanced average k-space speed and thus high acquisition efficiency. This renders spirals attractive for contemporary fMRI applications that require high spatiotemporal resolution, such as laminar or columnar fMRI. However, in practice, spiral fMRI is typically hampered by its reduced robustness and ensuing blurring artifacts, which arise from imperfections in both static and dynamic magnetic fields. Recently, these limitations have been overcome by the concerted application of an expanded signal model that accounts for such field imperfections, and its inversion by iterative image reconstruction. In the challenging ultra-high field environment of 7 Tesla, where field inhomogeneity effects are aggravated, both multi-shot and single-shot 2D spiral imaging at sub-millimeter resolution was demonstrated with high depiction quality and anatomical congruency. In this work, we further these advances towards a time series application of spiral readouts, namely, single-shot spiral BOLD fMRI at 0.8 mm in-plane resolution. We demonstrate that high-resolution spiral fMRI at 7 T is not only feasible, but delivers both excellent image quality, BOLD sensitivity, and spatial specificity of the activation maps, with little artifactual blurring. Furthermore, we show the versatility of the approach with a combined in/out spiral readout at a more typical resolution (1.5 mm), where the high acquisition efficiency allows to acquire two images per shot for improved sensitivity by echo combination.

Identifiants

pubmed: 34800666
pii: S1053-8119(21)01010-7
doi: 10.1016/j.neuroimage.2021.118738
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

118738

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest At the time of submission, Christoph Barmet and Bertram J. Wilm are employees of Skope Magnetic Resonance Technologies. Klaas P. Pruessmann holds a research agreement with and receives research support from Philips. He is a shareholder of Gyrotools LLC.

Auteurs

Lars Kasper (L)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland; Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Wilfriedstrasse 6, Zurich 8032, Switzerland. Electronic address: kasper@biomed.ee.ethz.ch.

Maria Engel (M)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland.

Jakob Heinzle (J)

Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Wilfriedstrasse 6, Zurich 8032, Switzerland.

Matthias Mueller-Schrader (M)

Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Wilfriedstrasse 6, Zurich 8032, Switzerland.

Nadine N Graedel (NN)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland; Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Jonas Reber (J)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland.

Thomas Schmid (T)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland.

Christoph Barmet (C)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland.

Bertram J Wilm (BJ)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland.

Klaas Enno Stephan (KE)

Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Wilfriedstrasse 6, Zurich 8032, Switzerland; Wellcome Centre for Human Neuroimaging, University College London, London WC1N 3BG, UK; Max Planck Institute for Metabolism Research, Cologne 50931, Germany.

Klaas P Pruessmann (KP)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Gloriastrasse 35, Zurich 8092, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH